![Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.npp.1300811/MediaObjects/41386_2005_Article_BF1300811_Fig1_HTML.jpg)
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology
![Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal](https://jpet.aspetjournals.org/content/jpet/288/1/260/F4.large.jpg)
Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal
![Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpp.2017.205/MediaObjects/41386_2018_Article_BFnpp2017205_Fig1_HTML.jpg)
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology
![The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females](https://www.science.org/cms/asset/1fe4f0a9-2c9f-4a91-bafe-e556ab9b5154/aay7550-f1.gif)
The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females
![Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnpp.2017.205/MediaObjects/41386_2018_Article_BFnpp2017205_Fig3_HTML.jpg)
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology
![Biology | Free Full-Text | Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer | HTML Biology | Free Full-Text | Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer | HTML](https://www.mdpi.com/biology/biology-09-00044/article_deploy/html/images/biology-09-00044-g001.png)
Biology | Free Full-Text | Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer | HTML
![Pregnancy‐Induced Adaptation in the Neuroendocrine Control of Prolactin Secretion - Grattan - 2008 - Journal of Neuroendocrinology - Wiley Online Library Pregnancy‐Induced Adaptation in the Neuroendocrine Control of Prolactin Secretion - Grattan - 2008 - Journal of Neuroendocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/468043d7-a606-489a-a60f-230456250cc2/jne_1661_f3.gif)
Pregnancy‐Induced Adaptation in the Neuroendocrine Control of Prolactin Secretion - Grattan - 2008 - Journal of Neuroendocrinology - Wiley Online Library
![Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal](https://jpet.aspetjournals.org/content/jpet/288/1/260/F1.large.jpg?download=true)
Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal
![Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.npp.1300811/MediaObjects/41386_2005_Article_BF1300811_Fig3_HTML.gif)
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology
![Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41386-018-0015-y/MediaObjects/41386_2018_15_Fig1_HTML.jpg)
Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology
![Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.npp.1300811/MediaObjects/41386_2005_Article_BF1300811_Fig2_HTML.gif)
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology
![Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers. - Abstract - Europe PMC Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2020834/bin/nihms25894f2.jpg)
Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers. - Abstract - Europe PMC
![Elevated Prolactin during Pregnancy Drives a Phenotypic Switch in Mouse Hypothalamic Dopaminergic Neurons - ScienceDirect Elevated Prolactin during Pregnancy Drives a Phenotypic Switch in Mouse Hypothalamic Dopaminergic Neurons - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124719300968-fx1.jpg)
Elevated Prolactin during Pregnancy Drives a Phenotypic Switch in Mouse Hypothalamic Dopaminergic Neurons - ScienceDirect
![Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnpp.2017.205/MediaObjects/41386_2018_Article_BFnpp2017205_Fig2_HTML.jpg)
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology
![Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITY | eNeuro Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITY | eNeuro](https://www.eneuro.org/content/7/4/ENEURO.0028-20.2020/F1.large.jpg)